期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Piperazine-derived ionizable lipids for enhanced mRNA delivery and cancer immunotherapy
1
作者 Kai Xu Yujia Xu +5 位作者 Jin Sun Xinwei Cheng Chenxi Lu Wenzhong Chen Bingfang He Tianyue Jiang 《Nano Research》 SCIE EI CSCD 2024年第8期7357-7364,共8页
Messenger ribonucleic acid(mRNA)-based therapeutics hold great prospects in disease treatment and lipid nanoparticles(LNPs)are the most extensively applied non-viral platform for RNA delivery in clinics.Despite the cl... Messenger ribonucleic acid(mRNA)-based therapeutics hold great prospects in disease treatment and lipid nanoparticles(LNPs)are the most extensively applied non-viral platform for RNA delivery in clinics.Despite the clinical success of LNPs as vehicles have been achieved,developing LNPs with enhanced mRNA transmembrane delivery and transfection efficiency in a non-toxic manner is highly desirable and challenging.In this study,we designed a series of new ionizable amino lipids with piperazinederived headgroups and constructed a group of LNPs to promote the transfection activity of mRNA cargos.Among them,LNP formulated with lipid 10(L10-LNP)can efficiently package mRNA and perform superior transfection efficiency both in vitro and in vivo,which is mainly attributed to the improved intracellular uptake and effective endosomal escape.We verified that a single administration of L10-LNP packaging interleukin(IL)-12 mRNA induced tumor shrink and even regression by robust activation of immune effector CD8^(+)T cells and stimulating the generation of IFN-γwithout causing systemic toxicity,which provides a promising platform for clinical cancer immunotherapy. 展开更多
关键词 ionizable lipid lipid nanoparticle piperazine-derived lipid mRNA therapeutics cancer immunotherapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部